APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sepsis Treatment

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Selected research

Market Structure

Global Sepsis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchSepsis Treatment Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Sepsis Treatment Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Sepsis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sepsis Treatment Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Sepsis Treatment Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.

Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.

Report Includes

Read the full market overview

This report provides an overview of the global Sepsis Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sepsis Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sepsis Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Sepsis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Sepsis Treatment Segment by Company

Pfizer

NCPC

Bayer

Shanghai Pharmaceuticals

Johnson & Johnson

Novartis

GlaxoSmithKline

TEVA

Mylan

Allergan

Merck & Co

Asahi Kasei Corporation

AtoxBio

INOTREM

Adrenomed

Endacea

Sepsis Treatment Segment by Type

Cephalosporin

Pencillin

Macrolides

Others

Sepsis Treatment Segment by Application

Sepsis

Severe Sepsis

Septic Shock

Sepsis Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sepsis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sepsis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sepsis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Sepsis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sepsis Treatment industry.

Chapter 3: Detailed analysis of Sepsis Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sepsis Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sepsis Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Cephalosporin Table 3. Key Players of Pencillin Table 4. Key Players of Macrolides Table 3. Key Players of Others Table 4. Global Sepsis Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Sepsis Table 6. Key Players of Severe Sepsis Table 7. Key Players of Septic Shock Table 8. Global Sepsis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Sepsis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Sepsis Treatment Market Share by Region (2021-2026) Table 11. Global Sepsis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Sepsis Treatment Market Share by Region (2027-2032) Table 13. Sepsis Treatment Industry Trends Table 14. Sepsis Treatment Industry Drivers Table 15. Sepsis Treatment Industry Opportunities and Challenges Table 16. Sepsis Treatment Industry Restraints Table 17. Global Sepsis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Sepsis Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Sepsis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Sepsis Treatment Key Company Head Office and Area Served Table 21. Global Sepsis Treatment Company, Product Type & Application Table 22. Global Sepsis Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Sepsis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Sepsis Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sepsis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Sepsis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Sepsis Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Sepsis Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Sepsis Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Sepsis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Sepsis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Sepsis Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Sepsis Treatment Revenue Market Share by Application (2027-2032) Table 35. Pfizer Company Information Table 36. Pfizer Business Overview Table 37. Pfizer Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Pfizer Sepsis Treatment Product Portfolio Table 39. Pfizer Recent Development Table 40. NCPC Company Information Table 41. NCPC Business Overview Table 42. NCPC Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. NCPC Sepsis Treatment Product Portfolio Table 44. NCPC Recent Development Table 45. Bayer Company Information Table 46. Bayer Business Overview Table 47. Bayer Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Bayer Sepsis Treatment Product Portfolio Table 49. Bayer Recent Development Table 50. Shanghai Pharmaceuticals Company Information Table 51. Shanghai Pharmaceuticals Business Overview Table 52. Shanghai Pharmaceuticals Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Shanghai Pharmaceuticals Sepsis Treatment Product Portfolio Table 54. Shanghai Pharmaceuticals Recent Development Table 55. Johnson & Johnson Company Information Table 56. Johnson & Johnson Business Overview Table 57. Johnson & Johnson Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Johnson & Johnson Sepsis Treatment Product Portfolio Table 59. Johnson & Johnson Recent Development Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novartis Sepsis Treatment Product Portfolio Table 64. Novartis Recent Development Table 65. GlaxoSmithKline Company Information Table 66. GlaxoSmithKline Business Overview Table 67. GlaxoSmithKline Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. GlaxoSmithKline Sepsis Treatment Product Portfolio Table 69. GlaxoSmithKline Recent Development Table 70. TEVA Company Information Table 71. TEVA Business Overview Table 72. TEVA Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. TEVA Sepsis Treatment Product Portfolio Table 74. TEVA Recent Development Table 75. Mylan Company Information Table 76. Mylan Business Overview Table 77. Mylan Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Mylan Sepsis Treatment Product Portfolio Table 79. Mylan Recent Development Table 80. Allergan Company Information Table 81. Allergan Business Overview Table 82. Allergan Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Allergan Sepsis Treatment Product Portfolio Table 84. Allergan Recent Development Table 85. Merck & Co Company Information Table 86. Merck & Co Business Overview Table 87. Merck & Co Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Merck & Co Sepsis Treatment Product Portfolio Table 89. Merck & Co Recent Development Table 90. Asahi Kasei Corporation Company Information Table 91. Asahi Kasei Corporation Business Overview Table 92. Asahi Kasei Corporation Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Asahi Kasei Corporation Sepsis Treatment Product Portfolio Table 94. Asahi Kasei Corporation Recent Development Table 95. AtoxBio Company Information Table 96. AtoxBio Business Overview Table 97. AtoxBio Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. AtoxBio Sepsis Treatment Product Portfolio Table 99. AtoxBio Recent Development Table 100. INOTREM Company Information Table 101. INOTREM Business Overview Table 102. INOTREM Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. INOTREM Sepsis Treatment Product Portfolio Table 104. INOTREM Recent Development Table 105. Adrenomed Company Information Table 106. Adrenomed Business Overview Table 107. Adrenomed Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Adrenomed Sepsis Treatment Product Portfolio Table 109. Adrenomed Recent Development Table 110. Endacea Company Information Table 111. Endacea Business Overview Table 112. Endacea Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Endacea Sepsis Treatment Product Portfolio Table 114. Endacea Recent Development Table 115. North America Sepsis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Sepsis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Sepsis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Sepsis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Sepsis Treatment Market Size by Country (2021-2026) Table 121. North America Sepsis Treatment Market Size by Country (2027-2032) Table 122. Europe Sepsis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Sepsis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Sepsis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Sepsis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Sepsis Treatment Market Size by Country (2021-2026) Table 128. Europe Sepsis Treatment Market Size by Country (2027-2032) Table 129. China Sepsis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 130. China Sepsis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 131. China Sepsis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 132. China Sepsis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Sepsis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Sepsis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Sepsis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Sepsis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Sepsis Treatment Market Size by Country (2021-2026) Table 139. Asia Sepsis Treatment Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Sepsis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Sepsis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Sepsis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Sepsis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Sepsis Treatment Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Sepsis Treatment Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Sepsis Treatment Product Image Figure 2. Global Sepsis Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Sepsis Treatment Market Share by Type: 2025 VS 2032 Figure 4. Cephalosporin Image Figure 5. Pencillin Image Figure 6. Macrolides Image Figure 7. Others Image Figure 8. Global Sepsis Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Sepsis Treatment Market Share by Application: 2025 VS 2032 Figure 10. Sepsis Image Figure 11. Severe Sepsis Image Figure 12. Septic Shock Image Figure 13. Global Sepsis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Sepsis Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Sepsis Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Sepsis Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Sepsis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Sepsis Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Sepsis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sepsis Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Sepsis Treatment Market Share by Type (2021-2032) Figure 26. North America Sepsis Treatment Market Share by Application (2021-2032) Figure 27. North America Sepsis Treatment Market Share by Country (2021-2032) Figure 28. United States Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Sepsis Treatment Market Share by Type (2021-2032) Figure 33. Europe Sepsis Treatment Market Share by Application (2021-2032) Figure 34. Europe Sepsis Treatment Market Share by Country (2021-2032) Figure 35. Germany Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Sepsis Treatment Market Share by Type (2021-2032) Figure 43. China Sepsis Treatment Market Share by Application (2021-2032) Figure 44. Asia Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Sepsis Treatment Market Share by Type (2021-2032) Figure 46. Asia Sepsis Treatment Market Share by Application (2021-2032) Figure 47. Asia Sepsis Treatment Market Share by Country (2021-2032) Figure 48. Japan Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Sepsis Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Sepsis Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Sepsis Treatment Market Share by Country (2021-2032) Figure 58. Brazil Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Sepsis Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporin
  • Pencillin
  • Macrolides
  • Others
Applications
  • Sepsis
  • Severe Sepsis
  • Septic Shock
Companies covered
  • Pfizer
  • NCPC
  • Bayer
  • Shanghai Pharmaceuticals
  • Johnson & Johnson
  • Novartis
  • GlaxoSmithKline
  • TEVA
  • Mylan
  • Allergan
  • Merck & Co
  • Asahi Kasei Corporation
  • AtoxBio
  • INOTREM
  • Adrenomed
  • Endacea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Sepsis Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Cephalosporin
  5. 1.2.3 Pencillin
  6. 1.2.4 Macrolides
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Sepsis Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Sepsis
  11. 1.3.3 Severe Sepsis
  12. 1.3.4 Septic Shock
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Sepsis Treatment Growth Trends by Region
  15. 1.5.1 Global Sepsis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Sepsis Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Sepsis Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Sepsis Treatment Market Dynamics
  1. 2.1 Sepsis Treatment Industry Trends
  2. 2.2 Sepsis Treatment Industry Drivers
  3. 2.3 Sepsis Treatment Industry Opportunities and Challenges
  4. 2.4 Sepsis Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Sepsis Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Sepsis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Sepsis Treatment Key Company Head office and Area Served
  4. 3.4 Global Sepsis Treatment Company, Product Type & Application
  5. 3.5 Global Sepsis Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Sepsis Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Sepsis Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Sepsis Treatment Tier 1, Tier 2, and Tier 3
4 Sepsis Treatment Market by Type
  1. 4.1 Global Sepsis Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Sepsis Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Sepsis Treatment Market Size Share by Type (2021-2032)
5 Sepsis Treatment Market by Application
  1. 5.1 Global Sepsis Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Sepsis Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Sepsis Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Sepsis Treatment Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 NCPC
  8. 6.2.1 NCPC Company Information
  9. 6.2.2 NCPC Business Overview
  10. 6.2.3 NCPC Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 NCPC Sepsis Treatment Product Portfolio
  12. 6.2.5 NCPC Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Bayer Sepsis Treatment Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 Shanghai Pharmaceuticals
  20. 6.4.1 Shanghai Pharmaceuticals Company Information
  21. 6.4.2 Shanghai Pharmaceuticals Business Overview
  22. 6.4.3 Shanghai Pharmaceuticals Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Shanghai Pharmaceuticals Sepsis Treatment Product Portfolio
  24. 6.4.5 Shanghai Pharmaceuticals Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Johnson & Johnson Sepsis Treatment Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Sepsis Treatment Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GlaxoSmithKline Sepsis Treatment Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 TEVA
  44. 6.8.1 TEVA Company Information
  45. 6.8.2 TEVA Business Overview
  46. 6.8.3 TEVA Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 TEVA Sepsis Treatment Product Portfolio
  48. 6.8.5 TEVA Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Mylan Sepsis Treatment Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Allergan
  56. 6.10.1 Allergan Company Information
  57. 6.10.2 Allergan Business Overview
  58. 6.10.3 Allergan Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Allergan Sepsis Treatment Product Portfolio
  60. 6.10.5 Allergan Recent Developments
  61. 6.11 Merck & Co
  62. 6.11.1 Merck & Co Company Information
  63. 6.11.2 Merck & Co Business Overview
  64. 6.11.3 Merck & Co Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Merck & Co Sepsis Treatment Product Portfolio
  66. 6.11.5 Merck & Co Recent Developments
  67. 6.12 Asahi Kasei Corporation
  68. 6.12.1 Asahi Kasei Corporation Company Information
  69. 6.12.2 Asahi Kasei Corporation Business Overview
  70. 6.12.3 Asahi Kasei Corporation Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Asahi Kasei Corporation Sepsis Treatment Product Portfolio
  72. 6.12.5 Asahi Kasei Corporation Recent Developments
  73. 6.13 AtoxBio
  74. 6.13.1 AtoxBio Company Information
  75. 6.13.2 AtoxBio Business Overview
  76. 6.13.3 AtoxBio Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AtoxBio Sepsis Treatment Product Portfolio
  78. 6.13.5 AtoxBio Recent Developments
  79. 6.14 INOTREM
  80. 6.14.1 INOTREM Company Information
  81. 6.14.2 INOTREM Business Overview
  82. 6.14.3 INOTREM Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 INOTREM Sepsis Treatment Product Portfolio
  84. 6.14.5 INOTREM Recent Developments
  85. 6.15 Adrenomed
  86. 6.15.1 Adrenomed Company Information
  87. 6.15.2 Adrenomed Business Overview
  88. 6.15.3 Adrenomed Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Adrenomed Sepsis Treatment Product Portfolio
  90. 6.15.5 Adrenomed Recent Developments
  91. 6.16 Endacea
  92. 6.16.1 Endacea Company Information
  93. 6.16.2 Endacea Business Overview
  94. 6.16.3 Endacea Sepsis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Endacea Sepsis Treatment Product Portfolio
  96. 6.16.5 Endacea Recent Developments
7 North America
  1. 7.1 North America Sepsis Treatment Market Size (2021-2032)
  2. 7.2 North America Sepsis Treatment Market Size by Type
  3. 7.2.1 North America Sepsis Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Sepsis Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Sepsis Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Sepsis Treatment Market Size by Application
  7. 7.3.1 North America Sepsis Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Sepsis Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Sepsis Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Sepsis Treatment Market Size by Country
  11. 7.4.1 North America Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Sepsis Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Sepsis Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Sepsis Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Sepsis Treatment Market Size (2021-2032)
  2. 8.2 Europe Sepsis Treatment Market Size by Type
  3. 8.2.1 Europe Sepsis Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Sepsis Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Sepsis Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Sepsis Treatment Market Size by Application
  7. 8.3.1 Europe Sepsis Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Sepsis Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Sepsis Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Sepsis Treatment Market Size by Country
  11. 8.4.1 Europe Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Sepsis Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Sepsis Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Sepsis Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Sepsis Treatment Market Size (2021-2032)
  2. 9.2 China Sepsis Treatment Market Size by Type
  3. 9.2.1 China Sepsis Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Sepsis Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Sepsis Treatment Market Share by Type (2021-2032)
  6. 9.3 China Sepsis Treatment Market Size by Application
  7. 9.3.1 China Sepsis Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Sepsis Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Sepsis Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Sepsis Treatment Market Size (2021-2032)
  2. 10.2 Asia Sepsis Treatment Market Size by Type
  3. 10.2.1 Asia Sepsis Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Sepsis Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Sepsis Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Sepsis Treatment Market Size by Application
  7. 10.3.1 Asia Sepsis Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Sepsis Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Sepsis Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Sepsis Treatment Market Size by Country
  11. 10.4.1 Asia Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Sepsis Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Sepsis Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Sepsis Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Sepsis Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Sepsis Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Sepsis Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Sepsis Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Sepsis Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Sepsis Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Sepsis Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Sepsis Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Sepsis Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Sepsis Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Sepsis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Sepsis Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Sepsis Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Sepsis Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst